Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Registrati

Quotazioni in diretta

ELVN Enliven Therapeutics Inc

27,63

-0,22 (-0,79%)

02 Nov 2024 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 06/29/2023, and all representations regarding material non-public information were made as of the adoption of the plan. The shares in this filing will be sold from The Patel/Dong Family Trust UAD 08/24/17.

Date of Notice

10/18/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

06/29/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Anish Patel

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Enliven Therapeutics (NASDAQ:ELVN)
Storico
Da Ott 2024 a Nov 2024

Clicca qui per i Grafici di Enliven Therapeutics

Grafico Azioni Enliven Therapeutics (NASDAQ:ELVN)
Storico
Da Nov 2023 a Nov 2024

Clicca qui per i Grafici di Enliven Therapeutics

Notizie Enliven Therapeutics Inc - ELVN

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 30 Ottobre 2024 (3 giorni fa) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Giovedì 24 Ottobre 2024 (1 settimana fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 22 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 22 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 22 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 22 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 22 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Sabatp 19 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 18 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 18 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 18 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 18 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Più Enliven Therapeutics Inc Articoli Notizie

Intesa Sanpaolo

ST Microelectronics

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea